SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-237892
Filing Date
2021-08-05
Accepted
2021-08-05 17:06:51
Documents
6
Effectiveness Date
2021-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d135044ds8.htm S-8 66710
2 EX-5.1 d135044dex51.htm EX-5.1 8077
3 EX-23.2 d135044dex232.htm EX-23.2 1670
4 GRAPHIC g135044dsp.jpg GRAPHIC 1947
5 GRAPHIC g135044dspa.jpg GRAPHIC 7072
6 GRAPHIC g135044dspb.jpg GRAPHIC 2008
  Complete submission text file 0001193125-21-237892.txt   93079
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258513 | Film No.: 211149364
SIC: 2834 Pharmaceutical Preparations